Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

May 31, 2006

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL

Live attenuated human rotavirus vaccine

Trial Locations (6)

GSK Investigational Site, Bucheon-si

GSK Investigational Site, Daejeon

GSK Investigational Site, Seoul

GSK Investigational Site, Jeonju

GSK Investigational Site, Seoul

GSK Investigational Site, Seoul